Annual CFO
$11.92 M
+$191.79 M+106.63%
December 31, 2023
Summary
- As of February 7, 2025, AMLX annual cash flow from operations is $11.92 million, with the most recent change of +$191.79 million (+106.63%) on December 31, 2023.
- During the last 3 years, AMLX annual CFO has risen by +$48.62 million (+132.48%).
- AMLX annual CFO is now at all-time high.
Performance
AMLX Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFO
-$41.57 M
+$25.01 M+37.56%
September 30, 2024
Summary
- As of February 7, 2025, AMLX quarterly cash flow from operations is -$41.57 million, with the most recent change of +$25.01 million (+37.56%) on September 30, 2024.
- Over the past year, AMLX quarterly CFO has dropped by -$36.40 million (-704.22%).
- AMLX quarterly CFO is now -406.77% below its all-time high of $13.55 million, reached on December 31, 2023.
Performance
AMLX Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFO
-$95.09 M
-$36.40 M-62.03%
September 30, 2024
Summary
- As of February 7, 2025, AMLX TTM cash flow from operations is -$95.09 million, with the most recent change of -$36.40 million (-62.03%) on September 30, 2024.
- Over the past year, AMLX TTM CFO has dropped by -$43.76 million (-85.25%).
- AMLX TTM CFO is now -676.22% below its all-time high of $16.50 million, reached on March 31, 2024.
Performance
AMLX TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
AMLX Cash From Operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +106.6% | -704.2% | -85.3% |
| 3 y3 years | +132.5% | -704.2% | -85.3% |
| 5 y5 years | +211.5% | -704.2% | -85.3% |
AMLX Cash From Operations Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +106.6% | -406.8% | +37.6% | -676.2% | +47.1% |
| 5 y | 5-year | at high | +106.6% | -406.8% | +37.6% | -676.2% | +47.1% |
| alltime | all time | at high | +106.6% | -406.8% | +37.6% | -676.2% | +47.1% |
Amylyx Pharmaceuticals Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$41.57 M(-37.6%) | -$95.09 M(+62.0%) |
| Jun 2024 | - | -$66.58 M(>+9900.0%) | -$58.69 M(-455.6%) |
| Mar 2024 | - | -$489.00 K(-103.6%) | $16.50 M(+38.5%) |
| Dec 2023 | $11.92 M(-106.6%) | $13.55 M(-362.2%) | $11.92 M(-123.2%) |
| Sep 2023 | - | -$5.17 M(-160.0%) | -$51.33 M(-42.5%) |
| Jun 2023 | - | $8.61 M(-269.7%) | -$89.24 M(-38.2%) |
| Mar 2023 | - | -$5.07 M(-89.8%) | -$144.31 M(-19.8%) |
| Dec 2022 | -$179.87 M | -$49.70 M(+15.4%) | -$179.87 M(+13.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2022 | - | -$43.08 M(-7.3%) | -$158.42 M(+16.3%) |
| Jun 2022 | - | -$46.46 M(+14.3%) | -$136.21 M(+32.5%) |
| Mar 2022 | - | -$40.63 M(+43.9%) | -$102.79 M(+37.4%) |
| Dec 2021 | -$74.80 M(+103.8%) | -$28.24 M(+35.4%) | -$74.80 M(+60.7%) |
| Sep 2021 | - | -$20.86 M(+59.9%) | -$46.55 M(+81.2%) |
| Jun 2021 | - | -$13.05 M(+3.2%) | -$25.69 M(+103.2%) |
| Mar 2021 | - | -$12.64 M | -$12.64 M |
| Dec 2020 | -$36.70 M(+243.4%) | - | - |
| Dec 2019 | -$10.69 M | - | - |
FAQ
- What is Amylyx Pharmaceuticals annual cash flow from operations?
- What is the all time high annual CFO for Amylyx Pharmaceuticals?
- What is Amylyx Pharmaceuticals annual CFO year-on-year change?
- What is Amylyx Pharmaceuticals quarterly cash flow from operations?
- What is the all time high quarterly CFO for Amylyx Pharmaceuticals?
- What is Amylyx Pharmaceuticals quarterly CFO year-on-year change?
- What is Amylyx Pharmaceuticals TTM cash flow from operations?
- What is the all time high TTM CFO for Amylyx Pharmaceuticals?
- What is Amylyx Pharmaceuticals TTM CFO year-on-year change?
What is Amylyx Pharmaceuticals annual cash flow from operations?
The current annual CFO of AMLX is $11.92 M
What is the all time high annual CFO for Amylyx Pharmaceuticals?
Amylyx Pharmaceuticals all-time high annual cash flow from operations is $11.92 M
What is Amylyx Pharmaceuticals annual CFO year-on-year change?
Over the past year, AMLX annual cash flow from operations has changed by +$191.79 M (+106.63%)
What is Amylyx Pharmaceuticals quarterly cash flow from operations?
The current quarterly CFO of AMLX is -$41.57 M
What is the all time high quarterly CFO for Amylyx Pharmaceuticals?
Amylyx Pharmaceuticals all-time high quarterly cash flow from operations is $13.55 M
What is Amylyx Pharmaceuticals quarterly CFO year-on-year change?
Over the past year, AMLX quarterly cash flow from operations has changed by -$36.40 M (-704.22%)
What is Amylyx Pharmaceuticals TTM cash flow from operations?
The current TTM CFO of AMLX is -$95.09 M
What is the all time high TTM CFO for Amylyx Pharmaceuticals?
Amylyx Pharmaceuticals all-time high TTM cash flow from operations is $16.50 M
What is Amylyx Pharmaceuticals TTM CFO year-on-year change?
Over the past year, AMLX TTM cash flow from operations has changed by -$43.76 M (-85.25%)